Report Description

The India polymerase chain reaction (PCR) devices market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include increasing incidences of chronic, infectious, and genetic diseases, rise in adoption of advanced techniques in the field of life sciences and rising awareness and demand for precision medicine, are propelling the growth of the market. Polymerase chain reaction (PCR) is a technique used in laboratory for rapidly producing or amplifying millions to billions of versions of a certain segment of DNA, which can then be studied in brief. The other factor which are bolstering the market growth are hasty investments in pharmaceutical and healthcare industry, growing population, expanding healthcare sector, growing R&D activities, increasing use of PCR techniques in clinical diagnostics, favorable initiatives undertaken by government bodies and rising health issues. Also, increasing demand for genetic testing procedures and rising inorganic strategic growth are facilitating the growth of the market.

Rising Prevalence of Infectious Diseases, Chronic Diseases, and Genetic Disorders

Growing incidences of infectious, chronic, and genetic diseases in the country are the key reasons for augmenting the growth of the market. Tuberculosis is one of the most common infectious diseases which is considerably prevalent in India. According to the WHO, in 2020, around 504,000 people died due to tuberculosis, which is 13% increase from previous year. Owing to the rise in people suffering from various types of diseases, the demand for the products for diagnosis is surging, which in turn, bolster the growth of the market. Also, the rise in geriatric population is driving the growth of the market. This is attributed to the surge in number of elderly people suffering from various diseases. According the first Longitudinal Ageing Study in India (LASI) announced by the Union Ministry of Family and Health Welfare in 2020, two in every three senior citizens suffer from some chronic disease.

Rising Technological Developments to support Market Growth

Rise in technological advancements and growing need for innovative devices is augmenting the growth of the market. The continuous technological advancements in PCR technologies such as miniaturized devices, miniaturized portable instruments, incorporation of robotics in devices and others are surging the growth of the market. This is due to the various clinical benefits provided by these devices to healthcare providers and patients. Over the past few years, there is drastic shift towards digital PCR diagnostic techniques, and automated instruments, which, in turn, fuels the growth of the market. For instance, in 2021, Thermo Fisher Scientific, announced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system intended to deliver highly accurate and reliable results within 90 minutes.

Rising Demand for Personalized and Precision Medicine

The rising awareness and demand for precision medicine is bolstering the growth of the market. People are being educated by the doctors about the benefits associated with personalized medicine. Precision medicine aims to offers tailor made therapies to individual people. The precision medicine is based on the patient’s genes, diseases and other. These medicines have enormous potential to cure various diseases, thus augmenting the growth of the market. Furthermore, precision, and personalized medicines have created massive opportunities in the field of genetic medicine. To facilitate personalized medicine, PCR are used to gather molecular information about the underlying disease. Thus, in turn, bolster the growth of the market.


Download Free Sample Report 

Market Segmentation

The India polymerase chain reaction (PCR) devices market is segmented into type, end user, and company. Based on type, the market is divided into quantitative PCR, digital PCR, and others. Based on end user, the market is further divided into hospitals & clinics, diagnostic laboratories, pharmaceutical & biotechnology companies, and others. Based on quantitative PCR, the market is further divided into product, application, and end user. Based on product, the market is further divided into reagents & consumables, instruments, and software & services. Based on application, the market is further divided into medical v/s non-medical. Based on medical application, the market is further divided into clinical applications, research, and forensics. Based on clinical applications, the market is further divided into pathogen testing, oncology testing, blood screening, and others. Based on research applications, the market is further divided into stem cell research, DNA cloning & sequencing, recombinant DNA technology, and others. Based on non-medical applications, the market is further divided into food, agricultural biotechnology, and others. Based on end user, the market is further divided into hospitals & clinics, diagnostic laboratories, pharmaceutical & biotechnology companies, and others. Based on digital PCR, the market is further divided into type, product, application, and end user. Based on type, the market is further divided into droplet digital PCR systems and chip-based digital PCR systems. Based on product, the market is divided into reagents & consumables, kits & assays, and systems. Based on application, the market is divided into oncology, infectious diseases, rare diseases, reproductive genetics, and others. Based on end user, the market is further divided into hospitals & clinics, diagnostic laboratories, pharmaceutical & biotechnology companies, and others. In terms of region, the market is segmented into south, east, west, and north.

 Market Players

Thermo Fisher Scientific India Private Limited, Bio-Rad Laboratories (India) Private Limited, Qiagen India Pvt Ltd, Cole-Parmer India Pvt. Ltd., Abbott India Limited, Roche Diagnostics India Pvt. Ltd., and Molbio Diagnostics Pvt. Ltd. are some of the leading companies operating in the market.


Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         End User

·         Company

Regional scope

South, East, West, and North

Key companies profiled

Thermo Fisher Scientific India Private Limited, Bio-Rad Laboratories (India) Private Limited, Qiagen India Pvt Ltd, Cole-Parmer India Pvt. Ltd., Abbott India Limited, Roche Diagnostics India Pvt. Ltd., and Molbio Diagnostics Pvt. Ltd.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, India polymerase chain reaction (PCR) devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         India Polymerase Chain Reaction (PCR) Devices Market, By Type:

o    Quantitative PCR

§  Product

§  Reagents & Consumables

§  Instruments

§  Software & Services

§  Application

§  Medical Applications

§  Clinical Applications

§  Pathogen Testing

§  Oncology Testing

§  Blood Screening

§  Others

§  Research Applications

§  Stem Cell Research

§  DNA Cloning & Sequencing

§  Recombinant DNA Technology

§  Others

§  Forensics

§  Non-Medical Applications

§  Food

§  Agricultural Biotechnology

§  Others

§  End User

§  Hospitals & Clinics

§  Diagnostic Laboratories

§  Pharmaceutical & Biotechnology Companies

§  Others

o    Digital PCR

§  Type

§  Droplet Digital PCR Systems

§  Chip-Based Digital PCR Systems

§  Product

§  Reagents & Consumables

§  Kits & Assays

§  Systems

§  Application

§  Oncology

§  Infectious Diseases

§  Rare Diseases

§  Reproductive Genetics

§  Others

§  End User

§  Hospitals & Clinics

§  Diagnostic Laboratories

§  Pharmaceutical & Biotechnology Companies

§  Others

·         India Polymerase Chain Reaction (PCR) Devices Market, By End User:

    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Others

·         India Polymerase Chain Reaction (PCR) Devices Market, By Region:

o    South

o    East

o    West

o    North

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present India polymerase chain reaction (PCR) devices market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Polymerase Chain Reaction (PCR) Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India Polymerase Chain Reaction (PCR) Devices Market

4.    Voice of Customer

5.    Executive Summary

6.    India Polymerase Chain Reaction Devices (PCR) Devices Rental Overview

7.    India Polymerase Chain Reaction (PCR) Devices Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Type (Quantitative PCR, Digital PCR, Others)

7.2.2.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others)

7.2.3.     By Region

7.2.3.1.         By State (Top 3 States)

7.2.4.     By Company (FY2022)

7.3.  Product Market Map

8.    India Quantitative Polymerase Chain Reaction (PCR) Devices Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Product (Reagents & Consumables, Instruments, Software & Services)

8.2.2.     By Application (Medical v/s non-Medical)

8.2.2.1.         Medical Applications (Clinical Applications, Research, Forensics)

8.2.2.1.1.             By Clinical Applications (Pathogen Testing, Oncology Testing, Blood Screening, Others)

8.2.2.1.2.             By Research Applications (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Others)

8.2.2.2.         By Non-Medical Applications (Food, Agricultural Biotechnology, Others)

8.2.3.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others)

8.3.  Pricing Analysis

9.    India Digital Polymerase Chain Reaction (PCR) Devices Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Type (Droplet Digital PCR Systems v/s Chip-Based Digital PCR Systems)

9.2.2.     By Product (Reagents & Consumables, Kits & Assays, Systems)

9.2.3.     By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)

9.2.4.     By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others)

9.3.  Pricing Analysis

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Developments

12.  Policy & Regulatory Landscape

13.  India Economic Profile

14.  Porters Five Forces Analysis

15.  PESTLE Analysis

16.  List of Polymerase Chain Reaction (PCR) Devices Suppliers (Up to 10, By Region)

17.  Competitive Landscape (Inclusive of SWOT Analysis)

17.1.              Thermo Fisher Scientific India Private Limited

17.2.              Bio-Rad Laboratories (India) Private Limited

17.3.              Qiagen India Pvt Ltd

17.4.              Cole-Parmer India Pvt. Ltd.

17.5.              Abbott India Limited

17.6.              Roche Diagnostics India Pvt. Ltd.

17.7.              Molbio Diagnostics Pvt. Ltd.

18.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increasing incidences of chronic, infectious, and genetic diseases, rise in adoption of advanced techniques in the field of life sciences and rising awareness and demand for precision medicine in the country are driving the demand for the India polymerase chain reaction (PCR) devices market.

down-arrow

Thermo Fisher Scientific India Private Limited, Bio-Rad Laboratories (India) Private Limited, Qiagen India Pvt Ltd, Cole-Parmer India Pvt. Ltd., Abbott India Limited, Roche Diagnostics India Pvt. Ltd., and Molbio Diagnostics Pvt. Ltd. are the key players operating in the India polymerase chain reaction (PCR) devices market.

down-arrow

The high qPCR device costs, and stringent regulatory policies are likely to hamper the growth of India polymerase chain reaction (PCR) devices market.

down-arrow

The India Polymerase Chain Reaction (PCR) Devices Market is segmented into type, end user, and company.

profile

Sakshi Bajaal

Business Consultant
Press Release

India Polymerase Chain Reaction (PCR) Devices Market to be dominated by Growing Technological Developments through 2027

Oct, 2022

Increasing incidences of infectious, chronic, and genetic diseases to drive the India polymerase chain reaction (PCR) devices market in the forecast period, 2023-2027